Institutional Ownership Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO). We have compiled data on the 169 institutions that hold shares in the stock, with a total of 162 Million shares, which have been reported (via 13F filing form) to have a value of $167 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Tpg Gp A, LLC
Fort Worth, TX |
Aug 14, 2025 Q2 2025 |
18,716,306
shares
|
$19.3 Million
1.28% of portfolio
|
Q4 2021
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,445,682
shares
|
$16.9 Million
0.0% of portfolio
|
Q2 2024
Added 70.37%
|
|
Capital World Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
11,150,000
shares
|
$11.5 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.09%
|
|
Lynx1 Capital Management LP
San Juan, PR |
Aug 14, 2025 Q2 2025 |
11,057,009
shares
|
$11.4 Million
3.7% of portfolio
|
Q1 2025
Added 1.68%
|
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
Aug 14, 2025 Q2 2025 |
10,479,791
shares
|
$10.8 Million
0.5% of portfolio
|
Q2 2025
Added 0.29%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
10,252,606
shares
|
$10.6 Million
0.0% of portfolio
|
Q2 2025
Added 0.48%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
8,259,128
shares
|
$8.51 Million
0.0% of portfolio
|
Q2 2025
Added 2.37%
|
|
Primecap Management CO
Pasadena, CA |
Aug 11, 2025 Q2 2025 |
5,719,140
shares
|
$5.89 Million
0.01% of portfolio
|
Q2 2025
Added 15.96%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
5,503,141
shares
|
$5.67 Million
0.0% of portfolio
|
Q2 2025
Reduced 5.99%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
5,136,797
shares
|
$5.29 Million
0.0% of portfolio
|
Q1 2025
Added 37.49%
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
4,360,608
shares
|
$4.49 Million
0.03% of portfolio
|
Q1 2025
Added 0.01%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
4,030,872
shares
|
$4.15 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.16%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
3,868,750
shares
|
$3.98 Million
0.23% of portfolio
|
Q1 2025
Added 34.91%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
3,794,827
shares
|
$3.91 Million
0.0% of portfolio
|
Q2 2025
Added 12.96%
|
|
Wildcat Capital Management, LLC
|
Jul 18, 2025 Q2 2025 |
2,920,787
shares
|
$3.01 Million
2.17% of portfolio
|
Q2 2024
Added 52.06%
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
Aug 12, 2025 Q2 2025 |
2,875,357
shares
|
$2.96 Million
1.83% of portfolio
|
Q2 2025
Reduced 16.61%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
2,736,419
shares
|
$2.82 Million
0.0% of portfolio
|
Q2 2025
Reduced 13.95%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,722,742
shares
|
$2.8 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.4%
|
|
Patient Square Capital LP
Menlo Park, CA |
Aug 11, 2025 Q2 2025 |
2,635,000
shares
|
$2.71 Million
1.07% of portfolio
|
Q2 2025
Added 11.27%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
2,038,919
shares
|
$2.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.86%
|
|
Vida Ventures Advisors, LLC
|
Jul 09, 2025 Q2 2025 |
1,798,163
shares
|
$1.85 Million
100.0% of portfolio
|
Q3 2020
New holding
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
1,767,400
shares
|
$1.82 Million
0.0% of portfolio
|
Q2 2025
Reduced 19.69%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,670,012
shares
|
$1.72 Million
0.0% of portfolio
|
Q2 2025
Added 7.28%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,613,225
shares
|
$1.66 Million
0.0% of portfolio
|
Q2 2025
Reduced 22.26%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
1,502,724
shares
|
$1.55 Million
0.0% of portfolio
|
Q2 2025
Added 485.06%
|